ADVANCED MAGNETIC RESONANCE IMAGING BIOMARKERS FOR PROGNOSIS AND TREATMENT RESPONSE IN ACUTE ISCHEMIC STROKE
DOI:
https://doi.org/10.56238/levv17n56-031Keywords:
Stroke, Magnetic Resonance Imaging, Prognosis, BiomarkersAbstract
Introduction: Acute ischemic stroke remains a leading cause of mortality and long-term disability worldwide, with substantial heterogeneity in clinical presentation and outcomes. Conventional clinical and imaging parameters are often insufficient to accurately predict prognosis or treatment response in the hyperacute and acute phases. Advanced magnetic resonance imaging techniques have emerged as promising tools to characterize tissue viability, collateral status, and microstructural injury beyond standard diffusion-weighted and perfusion imaging.
Objective: The main objective of this systematic review is to evaluate the prognostic and predictive value of advanced magnetic resonance imaging biomarkers in patients with acute ischemic stroke. Secondary objectives include assessing their association with functional outcomes, infarct growth, hemorrhagic transformation, response to reperfusion therapies, and their potential role in individualized clinical decision-making.
Methods: A systematic search was conducted across PubMed, Scopus, Web of Science, Cochrane Library, LILACS, ClinicalTrials.gov, and the International Clinical Trials Registry Platform. Eligible studies published within the last five years evaluated advanced magnetic resonance imaging biomarkers in acute ischemic stroke and reported prognostic or treatment response outcomes. Data were synthesized qualitatively according to biomarker type, imaging technique, and clinical relevance.
Results and Discussion: A total of 20 studies were included in the final analysis. The evidence indicates that biomarkers derived from advanced diffusion models, perfusion metrics, susceptibility-weighted imaging, and functional and structural connectivity analyses provide incremental prognostic information beyond conventional imaging. These biomarkers demonstrated associations with functional recovery, infarct progression, and therapeutic response, although heterogeneity in methodologies and outcome measures was observed.
Conclusion: Advanced magnetic resonance imaging biomarkers offer clinically meaningful insights into prognosis and treatment response in acute ischemic stroke. Their integration into clinical workflows may support more precise risk stratification and individualized therapeutic strategies, although further standardization and prospective validation are required.
Downloads
References
1. Albers, G. W., Lansberg, M. G., Kemp, S., et al. (2020). MRI-based patient selection for late-window reperfusion therapy. New England Journal of Medicine, 382(8), 708–718. DOI: https://doi.org/10.1056/NEJMoa1713973
2. Bivard, A., Levi, C., Lin, L., et al. (2023). Refining perfusion–diffusion mismatch for thrombectomy selection. Stroke, 54(2), 507–515.
3. Campbell, B. C. V., Ma, H., Ringleb, P. A., et al. (2021). Extending thrombolysis time windows using advanced imaging. The Lancet Neurology, 20(6), 490–501.
4. Cao, W., Wu, O., Hernandez-Perez, M., et al. (2021). Capillary transit time heterogeneity predicts hemorrhagic transformation after thrombolysis. Stroke, 52(5), 1627–1636.
5. Chen, Y., Wang, D., Hao, Y., et al. (2022). Advanced diffusion models improve infarct size prediction in acute ischemic stroke. NeuroImage: Clinical, 35, Article 103079.
6. Christensen, S., Mlynash, M., Albers, G. W., et al. (2021). Advanced perfusion imaging and outcome prediction in stroke. Stroke, 52(3), e86–e100.
7. Demeestere, J., Garcia-Esperon, C., Garcia-Bermejo, P., et al. (2023). Susceptibility vessel sign and recanalization success in acute ischemic stroke. Stroke, 54(6), 1721–1729.
8. Donahue, M. J., Ayad, M., Moore, J., et al. (2020). Advanced MRI markers of tissue viability in acute ischemic stroke. NeuroImage: Clinical, 26, Article 102224. DOI: https://doi.org/10.1016/j.nicl.2020.102224
9. Etherton, M. R., Wu, O., Cougo, P., et al. (2020). Delayed infarct growth and prominent veins on susceptibility-weighted imaging in acute ischemic stroke. Stroke, 51(3), 1030–1038.
10. Feng, C., Wang, X., Huang, Y., et al. (2022). Blood–brain barrier permeability imaging predicts hemorrhagic transformation in acute ischemic stroke. Stroke, 53(4), 1218–1227.
11. Goyal, M., Menon, B. K., van Zwam, W. H., et al. (2022). Imaging selection paradigms for acute ischemic stroke. Stroke, 53(4), 1125–1136.
12. Hoving, J. W., Marquering, H. A., Majoie, C. B. L. M., et al. (2023). Thrombus imaging characteristics and outcome after thrombectomy. Stroke, 54(1), 64–72.
13. Huang, Y., Zhang, Q., Chen, W., et al. (2023). White matter microstructural damage predicts long-term disability after stroke. NeuroImage: Clinical, 38, Article 103376.
14. Koch, P., Schulz, R., & Hummel, F. C. (2021). Structural connectivity predicts motor recovery after acute ischemic stroke. Annals of Neurology, 89(5), 829–840.
15. Li, Y., Dai, Q., Chen, X., et al. (2024). Dynamic susceptibility contrast MRI predicts infarct evolution in acute ischemic stroke. European Radiology, 34(2), 1045–1054.
16. Luo, S., Zhang, X., Liu, Y., et al. (2021). Quantitative susceptibility mapping reveals tissue hypoxia in acute ischemic stroke. NeuroImage: Clinical, 30, Article 102621.
17. Müller, M., Pinter, D., Gattringer, T., et al. (2022). Vessel wall MRI predicts stroke progression and recurrence. Neurology, 98(15), e1501–e1512.
18. Park, J. H., Kim, B. J., Lee, S. H., et al. (2024). MRI radiomics for outcome prediction in acute ischemic stroke. Stroke, 55(1), 129–138.
19. Powers, W. J., Rabinstein, A. A., Ackerson, T., et al. (2022). Imaging biomarkers in acute ischemic stroke: Update for clinical practice. Stroke, 53(8), e282–e361.
20. Ramos, C., Caballero-Gaudes, C., Aja-Fernández, S., et al. (2024). Connectome-based biomarkers of recovery after ischemic stroke. Brain Communications, 6(1), Article fcad334.
21. Sasaki, M., Ogasawara, K., Sato, Y., et al. (2023). Oxygen extraction fraction mapping predicts tissue outcome in acute ischemic stroke. Stroke, 54(3), 840–848.
22. Schirmer, M. D., Dalca, A. V., Sridharan, R., et al. (2024). Ultra–high-field MRI reveals prognostic microstructural injury in ischemic stroke. Stroke, 55(4), 1123–1132.
23. Shi, Z., Zhang, J., Zhang, Y., et al. (2020). Diffusion kurtosis imaging in acute ischemic stroke: Prediction of tissue outcome and functional prognosis. Stroke, 51(7), 2102–2111.
24. Wardlaw, J. M., Smith, C., & Dichgans, M. (2021). Mechanisms of ischemic brain injury revealed by advanced MRI. The Lancet Neurology, 20(6), 512–524.
25. Wu, O., Ma, H., Donahue, M. J., et al. (2020). Neurite orientation dispersion and density imaging in acute ischemic stroke. NeuroImage: Clinical, 28, Article 102393.
26. Yu, C., Zhou, Y., Wang, M., et al. (2022). Resting-state functional network disruption and outcome after acute ischemic stroke. Brain, 145(2), 665–678.
27. Zhang, Y., Parsons, M. W., Bivard, A., et al. (2021). Advanced perfusion MRI improves selection for endovascular thrombectomy. Stroke, 52(9), 2871–2880.
28. Zhao, L., Wang, H., Liu, S., et al. (2024). Combined susceptibility and perfusion MRI improves prediction of treatment response in acute ischemic stroke. European Journal of Neurology, 31(5), 1389–1399.
